Oncology MRI

Newly published research suggests the use of gadopiclenol at 0.05 mmol/kg is non-inferior to gadobutrol 0.1 mmol/kg for all qualitative visualization parameters on full-body magnetic resonance imaging (MRI).

Catch up on the top radiology content of the past week.

Superfluous pan scans have become standard for a vast majority of minor injury presentations in emergency room settings.

Catch up on the top AI-related news and research from the past month.

Catch up on the top radiology content of the past week.

For patients with residual or recurrent grade 2 isocitrate dehydrogenase (IDH)-mutant gliomas, magnetic resonance imaging (MRI) revealed that daily dosing of vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes, led to a median progression-free survival of 27.7 months in comparison to 11.1 months in a placebo group, according to new research presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Catch up on the top radiology content of the past week.

The combination of Philips’ MR 7700 multi-nuclei scanner with the FDA-approved Xenoview hyperpolarized Xenon magnetic resonance imaging (MRI) contrast agent may facilitate earlier diagnosis and intervention for patients with obstructive lung diseases.

The artificial intelligence (AI)-powered Ezra Flash reportedly enhances magnetic resonance imaging (MRI) and enables significant reductions in scan times and costs for full-body MRI.

Conditional use of full-body magnetic resonance imaging (MRI) is reportedly permitted for patients using any of the models for the remede® System, an implantable nerve stimulation therapy indicated for the treatment of adults with moderate to severe central sleep apnea.

Catch up on the top AI-related news and research from the past month.

Catch up on the top radiology content of the past week.

Catch up on the top radiology content of the past week.

While calling for a universal breast cancer risk assessment by the age of 25, the American College of Radiology (ACR) emphasized that ascertaining screening needs prior to the age of 40 is particularly important in high-risk populations such as Black women, who are 42 percent more likely to die from breast cancer in comparison to non-Hispanic White women.

In a review of the literature, this author discusses the viability of artificial intelligence (AI), parallel imaging, compressed sensing and simultaneous multi-slice excitation for improving the scan times and use of magnetic resonance imaging (MRI) to facilitate CyberKnife treatment.

Catch up on the top radiology content of the past week.

Researchers suggested that overnight use of a power-save mode on outpatient magnetic resonance imaging (MRI) devices in the United States could reduce annual energy consumption by 76,288.2 megawatt hours (MWh) and add up to $10.7 million in cost savings.

Lamenting a lack of control over imaging requests from referring clinicians, this author suggests that a more collaborative approach between referrers and radiologists may facilitate more efficient use of imaging.

Catch up on the top radiology content of the past week.

Given the increasing prevalence of breast reconstruction, researchers discussed key signs of common complications on magnetic resonance imaging (MRI), ultrasound and other imaging during a recent presentation at the American Roentgen Ray Society (ARRS) 2023 Annual Meeting in Honolulu, Hawaii.

Catch up on the top radiology content of the past week.

In a study of 128 patients who had breast magnetic resonance imaging (MRI) exams after COVID-19 booster vaccination, researchers noted that nearly 19 percent of the cohort had equal to or greater than 0.2 cm of increased lymph node cortical thickness.

Catch up on the top radiology content of the past week.

In a cum laude awarded presentation at the European Congress of Radiology (ECR), researchers discussed misconceptions and pertinent principles for magnetic resonance imaging (MRI) of patients with rectal cancer, ranging from the diagnosis of mucinous tumors to the impact of mesorectal fascia status for rectal cancer recurrence.

New research from the American Cancer Society comparing pre-pandemic cancer screening prevalence to the second year of the COVID-19 pandemic in the United States showed a 1.1 million decrease in breast cancer screenings, a 4.4 million decrease in cervical cancer screening and a 600,000 decrease in prostate cancer screenings.